Therapeutic effects of exogenous surfactant enriched with dextran in newborn rabbits with respiratory failure induced by airway instillation of albumin

Pulmonary Pharmacology and Therapeutics

Volumn 21, Issue 2, 2008, Pages 393-400

  Calkovska, A ^a   Some, M ^a   Linderholm, B ^a   Curstedt, T ^a   Robertson, B ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Albumin; ARDS; Dextran; Lung compliance; Pulmonary surfactants

Indexed keywords

ALBUMIN; DEXTRAN; OXYGEN; PORACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG INSTILLATION; DRUG MEGADOSE; DRUG POTENTIATION; EXPERIMENTAL RABBIT; GESTATIONAL AGE; LOW DRUG DOSE; LUNG COMPLIANCE; LUNG FUNCTION; LUNG MINUTE VOLUME; LUNG VENTILATION; MORPHOLOGY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RABBIT; RESPIRATORY FAILURE; STATISTICAL SIGNIFICANCE; THERAPY EFFECT; THORAX; TIDAL VOLUME; TREATMENT RESPONSE;

ACUTE DISEASE; ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL PRODUCTS; DEXTRANS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; GESTATIONAL AGE; HUMANS; LUNG COMPLIANCE; PHOSPHOLIPIDS; PULMONARY SURFACTANTS; RABBITS; RESPIRATORY INSUFFICIENCY; SERUM ALBUMIN;

EID: 39749096566     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2007.10.003     Document Type: Article

References (30)

1. Walther F.J. Surfactant therapy for neonatal lung disorders other than respiratory distress syndrome. In: Robertson B., and Taeusch H.W. (Eds). Surfactant therapy for lung disease (1995), Marcel Dekker, New York 461-476
2. Holm B.A., Notter R.H., and Finkelstein J.N. Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids. Chem Phys Lipids 38 (1985) 287-298
3. Keough K.M.W., Parsons C.S., Phang P.T., and Tweeddale M.G. Interactions between plasma proteins and pulmonary surfactant: surface balance studies. Can J Physiol Pharmacol 66 (1988) 1166-1173
4. Cockshutt A.M., Weitz J., and Possmayer F. Pulmonary surfactant-associated protein A enhances the surface properties of lipid extract surfactant and reverses inhibition by blood protein in vitro. Biochemistry 29 (1990) 8424-8429
5. Sun B., Curstedt T., Lindgren G., Franzen B., Alaiya A.A., Calkovska A., et al. Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A. Eur Respir J 10 (1997) 1967-1974
6. Taeusch H.W., Lu K.W., Goerke J., and Clements J.A. Nonionic polymers reverse inactivation of surfactant by meconium and other substances. Am J Respir Crit Care Med 159 (1999) 1391-1395
7. Lu K.W., Robertson B., and Taeusch H.W. Dextran or polyethylene glycol added to Curosurf for treatment of meconium lung injury in rats. Biol Neonate 88 1 (2005) 46-53
8. Tashiro K., Kobayashi T., and Robertson B. Dextran reduces surfactant inhibition by meconium. Acta Paediatr 89 (2000) 1439-1445
9. Calkovska A., Some M., Linderholm B., Johansson J., Curstedt T., and Robertson B. Biophysical and physiological properties of porcine surfactant enriched with polymyxin B. Biol Neonate 88 (2005) 101-108
10. Gustafsson L., Curstedt T., Johansson J., and Robertson B. Factors influencing spreading of Curosurf at an air-liquid interface. Biol Neonate 81 Suppl 1 (2002) 29-41
11. Lu J.J., Cheung W.W., Yu L.M., Policova Z., Li D., Hair M.L., et al. The effect of dextran to restore the activity of pulmonary surfactant inhibited by albumin. Respir Physiol Neurobiol 130 (2002) 169-179
12. Kobayashi T., Ohta K., Tashiro K., Nishizuka K., Chen W.-M., Ohmura S., et al. Dextran restores albumin-inhibited surface activity of pulmonary surfactant extract. J Appl Physiol 86 (1999) 1778-1784
13. Cui X.G., Tashiro K., Matsumoto H., Tsubokawa Y., and Kobayashi T. Aerosolized surfactant and dextran for experimental acute respiratory distress syndrome caused by acidified milk in rats. Acta Anaesthesiol Scand 47 (2003) 853-860
14. Calkovska A, Mokra D, Drgova A, Zila I, Javorka K. Bronchoalveolar lavage with pulmonary surfactant/dextran mixture improves meconium clearance and lung functions in experimental meconium aspiration syndrome. Eur J Pediatr 2007, DOI:10.1007/s00431-007-0596-7.
15. Mbagwu N., Bruni R., Hernández-Juviel J., Waring A.J., and Walther F.J. Sensitivity of synthetic surfactants to albumin inhibition in preterm rabbits. Mol Genet Metab 66 (1999) 40-48
16. Robertson B., Curstedt T., Johansson J., Jo{combining double acute accent}rnvall H., and Kobayashi T. Structural and functional characterization of porcine surfactant isolated by liquid-gel chromatography. Prog Respir Res 25 (1990) 237-246
17. Weibel E.R. Principles and methods for the morphometric study of the lung and other organs. Lab Invest 12 (1963) 131-155
18. Rigaut J.-P., and Robertson B. Quantitative evaluation of neonatal lung expansion with automated image analysis. Pediatr Pathol 6 (1986) 11-24
19. Berggren P., Rigaut J.P., Curstedt T., and Robertson B. Computerized image analysis of lung expansion patterns in surfactant treated immature newborn rabbits. Respir Physiol 115 (1999) 45-53
20. Seeger W., Grube C., Gunther A., and Schmidt R. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 6 (1993) 971-977
21. Kobayashi T., Nitta K., Ganzuka M., Inui S., Grossmann G., and Robertson B. Inactivation of exogenous surfactant by pulmonary edema fluid. Pediatr Res 29 (1991) 353-356
22. Espinosa F.F., and Kamm R.D. Bolus dispersal through the lungs in surfactant replacement therapy. J Appl Physiol 86 (1999) 391-410
23. King D.M., Wang Z., Palmer H.J., Holm B.A., and Notter R.H. Bulk shear viscosities of endogenous and exogenous lung surfactants. Am J Physiol Lung Cell Mol Physiol 282 (2002) L277-L284
24. Halliday H.L., and Speer C.P. Strategies for surfactant therapy in established neonatal respiratory distress syndrome. In: Robertson B., and Taeusch H.W. (Eds). Surfactant therapy for lung disease (1995), Marcel Dekker, New York 443-459
25. Tashiro K., Cui X.G., Kobayashi T., Curstedt T., and Robertson B. Modified protocols for surfactant therapy in experimental meconium aspiration syndrome. Biol Neonate 83 (2003) 49-56
26. Holm B.A., Enhorning G., and Notter R.H. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phys Lipids 49 (1988) 49-55
27. Meyuhas D., Nir S., and Lichtenberg D. Aggregation of phospholipid vesicles by water-soluble polymers. Biophys J 71 (1996) 2602-2612
28. Dargaville P.A., and Morley C.J. Overcoming surfactant inhibition with polymers. Acta Paediatr 89 (2000) 1397-1400
29. Chebotareva N.A., Kurganov B.I., and Livanova N.B. Biochemical effects of molecular crowding. Biochemistry (Moscow) 69 (2004) 1239-1251
30. Zasadzinski J.A., Alig T.F., Alonso C., de la Serna J.B., Perez-Gil J., and Taeusch H.W. Inhibition of pulmonary surfactant adsorption by serum and the mechanisms of reversal by hydrophilic polymers: theory. Biophys J 89 (2005) 1621-1629